Naval Daver, MD, University of Texas MD Anderson Cancer Center, Houston, TX, highlights the importance of genetic screening in acute myeloid leukemia (AML). Additionally, Dr Daver discusses what AML subtypes to test in order to choose treatment options, improve outcomes, and reduce treatment-related toxicities. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).